Home › Funds › CLARK ESTATES INC/NY › STTK

CLARK ESTATES INC/NY position in STTK

SHATTUCK LABS INC · Health Care

CLARK ESTATES INC/NY reported holding 1,416,447 shares of STTK (SHATTUCK LABS INC) in its Q3 2026 13F filing — a position valued at US$9.7M, representing 2.24% of its reported portfolio and ranking #12 among its reported holdings. CLARK ESTATES INC/NY has disclosed STTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.42M sh
Reported value held$9.66M
Portfolio Weight2.24%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CLARK ESTATES INC/NY's STTK position evolved

CLARK ESTATES INC/NY first disclosed a stake in STTK in Q3 2023 at 1,475,648 shares (US$2.2M). The position peaked in Q1 2024 at 1,475,648 shares, worth US$13.2M. Across 13 filings, CLARK ESTATES INC/NY increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 1,416,447 shares valued at US$9.7M — a reduction of -13,720 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.48M $2.24M New
Q4 2023 1.48M $10.52M Hold
Q1 2024 1.48M $13.19M Hold
Q2 2024 1.48M $5.70M Hold
Q3 2024 1.48M $5.15M Hold
Q4 2024 1.48M $1.79M Hold
Q1 2025 1.48M $1.40M Hold
Q2 2025 1.48M $1.17M Hold
Q3 2025 1.48M $3.53M Hold
Q4 2025 1.48M $5.39M Hold
Q1 2026 1.48M $9.49M Hold
Q2 2026 1.43M $9.93M Reduce
Q3 2026 1.42M $9.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STTK and 13F data

STTK (SHATTUCK LABS INC) is a Health Care company. 59 other funds we track also report a position in STTK — the largest reported positions include Redmile Group, LLC (US$47.8M), ORBIMED ADVISORS LLC (US$43.8M), Prosight Management, LP (US$41.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STTK

All STTK fund holders →

FAQ

How long has CLARK ESTATES INC/NY held STTK?

CLARK ESTATES INC/NY has disclosed STTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CLARK ESTATES INC/NY's current position in STTK?

As of Q3 2026, CLARK ESTATES INC/NY holds 1.42M shares of STTK (SHATTUCK LABS INC), valued at $9.66M, representing 2.24% of its reported portfolio and ranking #12.

Has CLARK ESTATES INC/NY been buying or selling STTK?

In the latest 13F filing (Q3 2026), CLARK ESTATES INC/NY reduced its position in STTK. The position peaked in Q1 2024 at 1.48M shares.

Which other funds hold STTK?

Other major institutional holders of STTK include Redmile Group, LLC, ORBIMED ADVISORS LLC, Prosight Management, LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.